US 11685771
Recombinant factor VIII proteins
granted A61KA61K35/14A61K38/00
Quick answer
US patent 11685771 (Recombinant factor VIII proteins) held by BIOVERATIV THERAPEUTICS INC. expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Jun 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K35/14, A61K38/00, A61K38/37, A61P